All In Biotech

Drug Trial Radar · NCT06329635

Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial

Trial of Treatment of Vasospasm Associated With Aneurysmal Subarachnoid Hemorrhage With Intrathecal Injection of Nicardipine: a Multi-center, Prospective, Double-blinded, Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Sep 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 396 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

396

Planned (sponsor's estimate)

Start

May 27, 2024

Primary completion

May 2026

Study completion May 2026

Sponsor

Lead sponsor
The Affiliated Hospital Of Guizhou Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To investigate whether patients with cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage have a better prognosis with intrathecal nicardipine injection via extraventricular drainage or lumbar drainage.

Conditions

  • Aneurysmal Subarachnoid Hemorrhage
  • Vasospasm

Interventions

  • Intrathecal NicardipineDrug

    First, 6 ml of cerebrospinal fluid is withdrawn from the EVD or LD catheter, and then 4 ml (4mg) of nicardipine is injected into the EVD or LD drain tube, followed by 2 ml normal saline solution, and then the EVD or LD tube is clamped for 2 hours, and then kept open as clinically necessary until the next dose (q12h) of medication.

  • No interventionOther

    A simulated "intrathecal administration" operation is performed by a dedicated physician who is unblinded to the group assignment, the EVD or LD tube is not opened, and no "drug" is given. The simulated administration process needs to be out of the patient's view (if awake patient) and out of the presence of study team personnel.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Dichotomized Modified Rankin Scale (mRS) 0-2 vs 3-6Time frame: Day 90±30, Day 365±60.

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Affiliated First Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • Beijing Tiantan Hospital, Affiliated to Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Chongqing Ninth People's Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • Qianfengdong Prefecture People's Hospital

    Kaili, G, China · Recruiting

  • Southern Medical University Zhujiang Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Affiliated South China Hospital of Shenzhen University

    Shenzhen, Guangdong, China · Recruiting

  • Nanning First People's Hospital

    Nanning, Guangxi, China · Recruiting

  • Jinyang Hospital Affiliated to Guizhou Medical University

    Guiyang, Guizhou, China · Recruiting

  • The Second Affiliated Hospital of Guizhou Medical University

    Kaili, Guizhou, China · Recruiting

  • Liupanshui City People's Hospital

    Liupanshui, Guizhou, China · Recruiting

  • People's Hospital of Qiannan Buyi and Miao Autonomous Prefecture, Guizhou Province

    Xingyi, Guizhou, China · Recruiting

  • Qianxinan Prefecture People's Hospital

    Xingyi, Guizhou, China · Recruiting

  • Xingyi City People's Hospital

    Xingyi, Guizhou, China · Recruiting

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Recruiting

  • Nanyang Central Hospital, Henan Province

    Nanyang, Henan, China · Recruiting

  • Baotou Central Hospital

    Baotou, Inner Mongolia, China · Recruiting

  • Changzhou First People's Hospital

    Changzhou, Jiangsu, China · Recruiting

  • The First People's Hospital of Zhenjiang City, Jiangsu Province

    Zhenjiang, Jiangsu, China · Recruiting

  • Ganzhou People's Hospital

    Ganzhou, Jiangxi, China · Recruiting

  • Jinggangshan University Affiliated Hospital

    Ji’an, Jiangxi, China · Recruiting

  • Taian Central Hospital, Shandong Province

    Tai’an, Shandong, China · Recruiting

  • Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • The First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China · Recruiting

  • West China Airport Hospital of Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • Western Medical University Affiliated Hospital

    Luzhou, Sichuan, China · Recruiting

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

  • Zhejiang Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.